HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression profiles of p53, p63, and p73 in benign salivary gland tumors.

Abstract
The tumor-suppressor protein p53 has recently been shown to belong to a family that includes two structurally related proteins, p63 and p73. In contrast to p53, p63 and p73 play an essential role in epithelial development, stem cell identity and cellular differentiation. Salivary gland tumors carry a wide spectrum of histopathological forms, which may share a common single-cell origin from the epithelial progenitor basal duct cells and have a different tendency of malignant progression. This study was performed to examine the expression of p53, p63, and p73 in benign salivary gland tumors. Expression and mutation of p53, p73, and p63 were examined by direct DNA sequencing, reverse transcription PCR using isoform-specific primers, and by immunohistochemistry in normal parotid tissue ( n=10), and various tumors of the salivary gland (42 pleomorphic adenomas, 12 myoepitheliomas, 8 basal cell adenomas, 5 oncocytomas, 5 canalicular adenomas, and 20 adenolymphomas). In normal parotid tissue the expression of p63 and p73 was restricted to few basal and myoepithelial cells. Ductal luminal and acinus cells were completely negative for the expression of all three family members. In contrast, in salivary gland tumors, strong nuclear staining for p63 and p73 was observed. Myoepithelial and basaloid cells and the basal epithelial layer of adenolyphomas and oncocytomas were positive for p63 and also, to a lesser extent, to p73. Mutations of p53 were detected in 4 of 42 (10%) pleomorphic adenomas, in 3 of 12 (25%) myoepitheliomas, and in 1 of 8 (13%) basal cell adenomas but not in other tumors. We failed to detect specific mutations of p63 and p73. Using isoform-specific PCR, we found that all isoforms of p63 were expressed in normal parotid tissue whereas the pleomorphic adenomas, myoepitehliomas, and basal cell adenomas dominantly expressed the transactivation-incompetent truncated isoforms. Our data indicate that p63 and p73 are upregulated in salivary gland tumors and may serve as a marker of epithelial and myoepithelial progenitor cells in salivary glands. The prevalence of p53 mutations and the observation of the expression of DeltaNp63 isoforms only in pleomorphic adenomas, myoepitheliomas, and also basal cell adenomas may reflect their possible malignant potential.
AuthorsAnette Weber, Larissa Langhanki, Alexander Schütz, Andreas Gerstner, Friedrich Bootz, Christian Wittekind, Andrea Tannapfel
JournalVirchows Archiv : an international journal of pathology (Virchows Arch) Vol. 441 Issue 5 Pg. 428-36 (Nov 2002) ISSN: 0945-6317 [Print] Germany
PMID12447671 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CKAP4 protein, human
  • DNA Primers
  • DNA, Neoplasm
  • DNA-Binding Proteins
  • Membrane Proteins
  • Nuclear Proteins
  • Phosphoproteins
  • RNA, Messenger
  • RNA, Neoplasm
  • TP73 protein, human
  • Trans-Activators
  • Tumor Protein p73
  • Tumor Suppressor Protein p53
  • Tumor Suppressor Proteins
Topics
  • Adenoma, Pleomorphic (metabolism, pathology)
  • DNA Mutational Analysis
  • DNA Primers (chemistry)
  • DNA, Neoplasm (analysis)
  • DNA-Binding Proteins (biosynthesis, genetics)
  • Fluorescent Antibody Technique, Indirect
  • Gene Expression Profiling
  • Genes, Tumor Suppressor
  • Immunoenzyme Techniques
  • Membrane Proteins
  • Nuclear Proteins (biosynthesis, genetics)
  • Oligonucleotide Array Sequence Analysis
  • Parotid Neoplasms (metabolism, pathology)
  • Phosphoproteins (biosynthesis, genetics)
  • RNA, Messenger (metabolism)
  • RNA, Neoplasm (analysis)
  • Retrospective Studies
  • Reverse Transcriptase Polymerase Chain Reaction
  • Trans-Activators (biosynthesis, genetics)
  • Tumor Protein p73
  • Tumor Suppressor Protein p53 (biosynthesis, genetics)
  • Tumor Suppressor Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: